Willey K - Search Results

1

Regression of microalbuminuria: results of a controlled study, indapamide versus captopril.

Flack JR, Molyneaux L, Willey K, Yue DK. Flack JR, et al. Among authors: willey k. J Cardiovasc Pharmacol. 1993;22 Suppl 6:S75-7. J Cardiovasc Pharmacol. 1993. PMID: 7508065 Clinical Trial.

2

Obese patients with type 2 diabetes poorly controlled by insulin and metformin: effects of adjunctive dexfenfluramine therapy on glycaemic control.

Willey KA, Molyneaux LM, Yue DK. Willey KA, et al. Diabet Med. 1994 Aug-Sep;11(7):701-4. doi: 10.1111/j.1464-5491.1994.tb00336.x. Diabet Med. 1994. PMID: 7955998 Clinical Trial.

3

Comparative effects of indapamide and captopril on blood pressure and albumin excretion rate in diabetic microalbuminuria.

Donnelly R, Molyneaux LM, Willey KA, Yue DK. Donnelly R, et al. Among authors: willey ka. Am J Cardiol. 1996 Feb 22;77(6):26B-30B. doi: 10.1016/s0002-9149(97)89237-5. Am J Cardiol. 1996. PMID: 8848991 Review.

4

Indapamide is as effective as captopril in the control of microalbuminuria in diabetes.

Molyneaux LM, Willey KA, Yue DK. Molyneaux LM, et al. Among authors: willey ka. J Cardiovasc Pharmacol. 1996 Mar;27(3):424-7. doi: 10.1097/00005344-199603000-00016. J Cardiovasc Pharmacol. 1996. PMID: 8907805 Clinical Trial.

5

Does insulin therapy have a hypertensive effect in type 2 diabetes?

Genev NM, Lau IT, Willey KA, Molyneaux LM, Xu ZR, Zilkens RR, Wyndham RN, Yue DK. Genev NM, et al. Among authors: willey ka. J Cardiovasc Pharmacol. 1998 Jul;32(1):39-41. doi: 10.1097/00005344-199807000-00006. J Cardiovasc Pharmacol. 1998. PMID: 9676718 Clinical Trial.

6

The effects of dexfenfluramine on blood glucose control in patients with type 2 diabetes.

Willey KA, Molyneaux LM, Overland JE, Yue DK. Willey KA, et al. Diabet Med. 1992 May;9(4):341-3. doi: 10.1111/j.1464-5491.1992.tb01793.x. Diabet Med. 1992. PMID: 1600704 Clinical Trial.

7

Albuminuria is an independent predictor of carotid intima-media thickness and atherosclerosis in NIDDM patients.

Willey KA, Kidd JF, Harris JP, Xu ZR, Yue DK. Willey KA, et al. Diabetes Care. 1995 Nov;18(11):1502-3. doi: 10.2337/diacare.18.11.1502. Diabetes Care. 1995. PMID: 8722078 No abstract available.

8

Reflectance meter type and management of gestational diabetes.

Harmelin D, Robin H, Molyneaux L, Hoskins P, Fowler P, Forrest J, Willey K, Ellwood D, Waibuta K, Yue DK, et al. Harmelin D, et al. Among authors: willey k. Lancet. 1990 Mar 24;335(8691):735-6. doi: 10.1016/0140-6736(90)90857-2. Lancet. 1990. PMID: 1969098 No abstract available.

9

Single-visit screening of diabetic complications.

McGill MJ, Yue DK, Plehwe WE, Willey KA, Turtle JR. McGill MJ, et al. Among authors: willey ka. Diabetes Care. 1989 Sep;12(8):599-600. doi: 10.2337/diacare.12.8.599. Diabetes Care. 1989. PMID: 2776593 No abstract available.

10

Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation.

Babiy AV, Gebicki JM, Sullivan DR, Willey K. Babiy AV, et al. Among authors: willey k. Biochem Pharmacol. 1992 Mar 3;43(5):995-1000. doi: 10.1016/0006-2952(92)90604-h. Biochem Pharmacol. 1992. PMID: 1554398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters